跳至主要内容
临床试验/CTRI/2022/08/044543
CTRI/2022/08/044543尚未招募2 期

A Clinical Evaluation of a Unani Polyherbal Formulation in Management of Sala-e-Reham ( Uterine Fibroid) - An Open Label Single Arm Study

Ayurvedic and Unani Tibbia College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Women in reproductive age group(20-45years) diagnosed with uterine fibroid upto 2-3cm.
  • Patient coming with pelvic pain, pelvic lump, menorrhagia with regular cycles.
  • Patient willing to sign the informed consent follow the protocol and participate in clinical trial voluntarily.

排除标准

  • Patient unwilling to sign the consent form.
  • Patients who have abnormal finding such as hemorrhagic cyst, tubo-ovarian mass, suspected pregnancy, bicornuate uterus and septate uterus in ultrasonography will be excluded from the study.
  • Patient taking Hormonal therapy.
  • Patient having history of AIDS, Syphilis, and Gonorrhea.
  • History of Cardiovascular, Renal and Liver Disease.
  • History of Diabetes (Type 1 or Type 2)
  • History of Thyroid disease.
  • History of Bleeding disorder.
  • Patient having IUCD.
  • Patients with systemic disease and malignancy.

研究者

发起方
Ayurvedic and Unani Tibbia College and Hospital

相似试验